Stay updated with breaking news from Amrep Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts’ new coverage for Tuesday, May 23rd: StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. StockNews.com began coverage on shares of Aspira Women’s Health (NYSE:AWH). The firm issued a sell rating on the stock. CL King began coverage on shares of Axonics (NASDAQ:AXNX). CL King […]
Analysts’ new coverage for Monday, May 15th: StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. Citigroup Inc. initiated coverage on shares of AerCap (NYSE:AER). The firm issued a buy rating and a $71.00 price target on the stock. Citigroup Inc. initiated coverage on shares of […]
Stock Analysts’ new coverage for Sunday, May 7th: StockNews.com began coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). They issued a buy rating on the stock. StockNews.com started coverage on shares of AMREP (NYSE:AXR). The firm issued a buy rating on the stock. StockNews.com initiated coverage on shares of BSQUARE (NASDAQ:BSQR). The firm issued a sell […]
AMREP Co. (NYSE:AXR – Get Rating) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 20,600 shares, an increase of 14.4% from the March 31st total of 18,000 shares. Approximately 0.7% of the shares of the company are short sold. Based on an […]
AMREP Co. (NYSE:AXR – Get Rating)’s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $12.19 and traded as high as $15.26. AMREP shares last traded at $15.11, with a volume of 23,151 shares traded. Analyst Upgrades and Downgrades Separately, StockNews.com assumed coverage […]